76
|
Gordon J, McEwan P, Hurst M, Puelles J. The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus. Diabetes Ther 2016; 7:825-845. [PMID: 27787778 PMCID: PMC5118244 DOI: 10.1007/s13300-016-0206-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/23/2016] [Indexed: 01/31/2023] Open
Abstract
INTRODUCTION ENDURE (ClinicalTrials.gov identifier, NCT00856284), a multicenter, double-blind, active-controlled study of 2639 patients with uncontrolled type 2 diabetes mellitus (T2DM), found that metformin in combination with alogliptin (12.5 and 25 mg doses), when compared to standard add-on therapy (sulfonylurea, SU), exerted sustained antihyperglycemic effects over 2 years. This economic analysis of ENDURE aimed to quantify the relationship between increased glycemic durability and cost-effectiveness of alogliptin in the UK clinical setting, and communicate its sustained glycemic benefit in economic terms. METHODS Using baseline characteristics and treatment effects from the ENDURE trial population, between-group cost-effectiveness analyses compared the combined use of metformin and alogliptin (MET + ALO12.5/25) in patients with inadequately controlled T2DM, as an alternative to metformin and SU (MET + SU). In scenario analyses, an intragroup cost-effectiveness analysis compared MET + ALO12.5/25 with MET + SU; a between-group cost-effectiveness analysis also compared MET + ALO12.5/25 versus MET + SU within a subpopulation of patients who achieved HbA1c control (<7.5%) at 2 years on study drug. RESULTS Compared with baseline profiles of patients, combination therapies with alogliptin or SU were associated with improvements in length and quality of life and were cost-effective at established norms. Despite increased drug acquisition costs, alogliptin at 12.5 mg and 25 mg doses resulted in greater predicted lifetime quality-adjusted life year (QALY) gains with associated incremental cost-effectiveness ratios (ICERs) of £10,959/QALY and £7217/QALY compared to SU, respectively. CONCLUSION The ENDURE trial and the present cost-effectiveness analysis found that the glycemic durability of alogliptin therapy was associated with improved long-term patient outcomes, QALY gains, and ICERs that were cost-effective when evaluated against standard threshold values. Alogliptin therefore represents a cost-effective treatment alternative to SU as add-on therapy to metformin in patients with poorly managed T2DM. FUNDING Takeda Development Centre Europe Ltd.
Collapse
|
77
|
Aab A, Abreu P, Aglietta M, Ahn EJ, Al Samarai I, Albuquerque IFM, Allekotte I, Allen JD, Allison P, Almela A, Alvarez Castillo J, Alvarez-Muñiz J, Ambrosio M, Anastasi GA, Anchordoqui L, Andrada B, Andringa S, Aramo C, Arqueros F, Arsene N, Asorey H, Assis P, Aublin J, Avila G, Badescu AM, Baus C, Beatty JJ, Becker KH, Bellido JA, Berat C, Bertaina ME, Bertou X, Biermann PL, Billoir P, Biteau J, Blaess SG, Blanco A, Blazek J, Bleve C, Blümer H, Boháčová M, Boncioli D, Bonifazi C, Borodai N, Botti AM, Brack J, Brancus I, Bretz T, Bridgeman A, Briechle FL, Buchholz P, Bueno A, Buitink S, Buscemi M, Caballero-Mora KS, Caccianiga B, Caccianiga L, Cancio A, Canfora F, Caramete L, Caruso R, Castellina A, Cataldi G, Cazon L, Cester R, Chavez AG, Chiavassa A, Chinellato JA, Chirinos Diaz JC, Chudoba J, Clay RW, Colalillo R, Coleman A, Collica L, Coluccia MR, Conceição R, Contreras F, Cooper MJ, Coutu S, Covault CE, Cronin J, Dallier R, D'Amico S, Daniel B, Dasso S, Daumiller K, Dawson BR, de Almeida RM, de Jong SJ, De Mauro G, de Mello Neto JRT, De Mitri I, de Oliveira J, de Souza V, Debatin J, Del Peral L, Deligny O, Dhital N, Di Giulio C, Di Matteo A, Díaz Castro ML, Diogo F, Dobrigkeit C, D'Olivo JC, Dorofeev A, Dos Anjos RC, Dova MT, Dundovic A, Ebr J, Engel R, Erdmann M, Erfani M, Escobar CO, Espadanal J, Etchegoyen A, Falcke H, Fang K, Farrar GR, Fauth AC, Fazzini N, Ferguson AP, Fick B, Figueira JM, Filevich A, Filipčič A, Fratu O, Freire MM, Fujii T, Fuster A, Gallo F, García B, Garcia-Pinto D, Gate F, Gemmeke H, Gherghel-Lascu A, Ghia PL, Giaccari U, Giammarchi M, Giller M, Głas D, Glaser C, Glass H, Golup G, Gómez Berisso M, Gómez Vitale PF, González N, Gookin B, Gordon J, Gorgi A, Gorham P, Gouffon P, Griffith N, Grillo AF, Grubb TD, Guarino F, Guedes GP, Hampel MR, Hansen P, Harari D, Harrison TA, Harton JL, Hasankiadeh Q, Haungs A, Hebbeker T, Heck D, Heimann P, Herve AE, Hill GC, Hojvat C, Hollon N, Holt E, Homola P, Hörandel JR, Horvath P, Hrabovský M, Huege T, Hulsman J, Insolia A, Isar PG, Jandt I, Jansen S, Jarne C, Johnsen JA, Josebachuili M, Kääpä A, Kambeitz O, Kampert KH, Kasper P, Katkov I, Keilhauer B, Kemp E, Kieckhafer RM, Klages HO, Kleifges M, Kleinfeller J, Krause R, Krohm N, Kuempel D, Kukec Mezek G, Kunka N, Kuotb Awad A, LaHurd D, Latronico L, Lauscher M, Lautridou P, Lebrun P, Legumina R, Leigui de Oliveira MA, Letessier-Selvon A, Lhenry-Yvon I, Link K, Lopes L, López R, López Casado A, Lucero A, Malacari M, Mallamaci M, Mandat D, Mantsch P, Mariazzi AG, Marin V, Mariş IC, Marsella G, Martello D, Martinez H, Martínez Bravo O, Masías Meza JJ, Mathes HJ, Mathys S, Matthews J, Matthews JAJ, Matthiae G, Maurizio D, Mayotte E, Mazur PO, Medina C, Medina-Tanco G, Mello VBB, Melo D, Menshikov A, Messina S, Micheletti MI, Middendorf L, Minaya IA, Miramonti L, Mitrica B, Molina-Bueno L, Mollerach S, Montanet F, Morello C, Mostafá M, Moura CA, Müller G, Muller MA, Müller S, Naranjo I, Navas S, Necesal P, Nellen L, Nelles A, Neuser J, Nguyen PH, Niculescu-Oglinzanu M, Niechciol M, Niemietz L, Niggemann T, Nitz D, Nosek D, Novotny V, Nožka H, Núñez LA, Ochilo L, Oikonomou F, Olinto A, Pakk Selmi-Dei D, Palatka M, Pallotta J, Papenbreer P, Parente G, Parra A, Paul T, Pech M, Pedreira F, Pękala J, Pelayo R, Peña-Rodriguez J, Pepe IM, Pereira LAS, Perrone L, Petermann E, Peters C, Petrera S, Phuntsok J, Piegaia R, Pierog T, Pieroni P, Pimenta M, Pirronello V, Platino M, Plum M, Porowski C, Prado RR, Privitera P, Prouza M, Quel EJ, Querchfeld S, Quinn S, Rautenberg J, Ravel O, Ravignani D, Revenu B, Ridky J, Risse M, Ristori P, Rizi V, Rodrigues de Carvalho W, Rodriguez Rojo J, Rodríguez-Frías MD, Rogozin D, Rosado J, Roth M, Roulet E, Rovero AC, Saffi SJ, Saftoiu A, Salazar H, Saleh A, Salesa Greus F, Salina G, Sanabria Gomez JD, Sánchez F, Sanchez-Lucas P, Santos EM, Santos E, Sarazin F, Sarkar B, Sarmento R, Sarmiento-Cano C, Sato R, Scarso C, Schauer M, Scherini V, Schieler H, Schmidt D, Scholten O, Schoorlemmer H, Schovánek P, Schröder FG, Schulz A, Schulz J, Schumacher J, Sciutto SJ, Segreto A, Settimo M, Shadkam A, Shellard RC, Sigl G, Sima O, Śmiałkowski A, Šmída R, Snow GR, Sommers P, Sonntag S, Sorokin J, Squartini R, Stanca D, Stanič S, Stapleton J, Stasielak J, Strafella F, Stutz A, Suarez F, Suarez Durán M, Sudholz T, Suomijärvi T, Supanitsky AD, Sutherland MS, Swain J, Szadkowski Z, Taborda OA, Tapia A, Tepe A, Theodoro VM, Timmermans C, Todero Peixoto CJ, Tomankova L, Tomé B, Tonachini A, Torralba Elipe G, Torres Machado D, Travnicek P, Trini M, Ulrich R, Unger M, Urban M, Valbuena-Delgado A, Valdés Galicia JF, Valiño I, Valore L, van Aar G, van Bodegom P, van den Berg AM, van Vliet A, Varela E, Vargas Cárdenas B, Varner G, Vázquez JR, Vázquez RA, Veberič D, Verzi V, Vicha J, Videla M, Villaseñor L, Vorobiov S, Wahlberg H, Wainberg O, Walz D, Watson AA, Weber M, Weindl A, Wiencke L, Wilczyński H, Winchen T, Wittkowski D, Wundheiler B, Wykes S, Yang L, Yapici T, Yelos D, Zas E, Zavrtanik D, Zavrtanik M, Zepeda A, Zimmermann B, Ziolkowski M, Zong Z, Zuccarello F. Testing Hadronic Interactions at Ultrahigh Energies with Air Showers Measured by the Pierre Auger Observatory. PHYSICAL REVIEW LETTERS 2016; 117:192001. [PMID: 27858429 DOI: 10.1103/physrevlett.117.192001] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/23/2016] [Indexed: 06/06/2023]
Abstract
Ultrahigh energy cosmic ray air showers probe particle physics at energies beyond the reach of accelerators. Here we introduce a new method to test hadronic interaction models without relying on the absolute energy calibration, and apply it to events with primary energy 6-16 EeV (E_{CM}=110-170 TeV), whose longitudinal development and lateral distribution were simultaneously measured by the Pierre Auger Observatory. The average hadronic shower is 1.33±0.16 (1.61±0.21) times larger than predicted using the leading LHC-tuned models EPOS-LHC (QGSJetII-04), with a corresponding excess of muons.
Collapse
|
78
|
Ostermayr TM, Haffa D, Hilz P, Pauw V, Allinger K, Bamberg KU, Böhl P, Bömer C, Bolton PR, Deutschmann F, Ditmire T, Donovan ME, Dyer G, Gaul E, Gordon J, Hegelich BM, Kiefer D, Klier C, Kreuzer C, Martinez M, McCary E, Meadows AR, Moschüring N, Rösch T, Ruhl H, Spinks M, Wagner C, Schreiber J. Proton acceleration by irradiation of isolated spheres with an intense laser pulse. Phys Rev E 2016; 94:033208. [PMID: 27739766 DOI: 10.1103/physreve.94.033208] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2016] [Indexed: 11/07/2022]
Abstract
We report on experiments irradiating isolated plastic spheres with a peak laser intensity of 2-3×10^{20}Wcm^{-2}. With a laser focal spot size of 10 μm full width half maximum (FWHM) the sphere diameter was varied between 520 nm and 19.3 μm. Maximum proton energies of ∼25 MeV are achieved for targets matching the focal spot size of 10 μm in diameter or being slightly smaller. For smaller spheres the kinetic energy distributions of protons become nonmonotonic, indicating a change in the accelerating mechanism from ambipolar expansion towards a regime dominated by effects caused by Coulomb repulsion of ions. The energy conversion efficiency from laser energy to proton kinetic energy is optimized when the target diameter matches the laser focal spot size with efficiencies reaching the percent level. The change of proton acceleration efficiency with target size can be attributed to the reduced cross-sectional overlap of subfocus targets with the laser. Reported experimental observations are in line with 3D3V particle in cell simulations. They make use of well-defined targets and point out pathways for future applications and experiments.
Collapse
|
79
|
Michael H, Gordon J, Chan S. 19 Impact OF Electronic Medical Record System on CT Scan Use in Recurrent Abdominal Pain Patients. Ann Emerg Med 2016. [DOI: 10.1016/j.annemergmed.2016.08.029] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
80
|
Lambe NR, McLean KA, Gordon J, Evans D, Clelland N, Bunger L. Prediction of intramuscular fat content using CT scanning of packaged lamb cuts and relationships with meat eating quality. Meat Sci 2016; 123:112-119. [PMID: 27701028 DOI: 10.1016/j.meatsci.2016.09.008] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2016] [Revised: 08/25/2016] [Accepted: 09/18/2016] [Indexed: 11/25/2022]
Abstract
Novel, multi-object X-ray computed tomography (CT) methodologies can individually analyse vacuum-packed meat samples scanned in batches of three or more, saving money and time compared to scanning live animals. If intramuscular fat (IMF), as a proxy for meat quality, can be predicted with similar accuracies as in live lambs, this method could be used to grade on quality, or to inform breeding programmes. Lamb loin cuts from commercial carcasses (n=303), varying in fat and conformation grade, were vacuum-packed and CT scanned, then tested for meat quality traits and by a trained taste panel. Tissue density values measured by CT, alongside carcass and loin weights, predicted IMF with moderate accuracy (R2 0.36), but did not accurately predict shear force or sensory traits. Juiciness and flavour increased linearly with IMF, whilst texture and overall liking increased to an optimum between 4 and 5% IMF. Samples predicted by CT as having >3% IMF scored significantly higher for sensory traits, than those predicted as <3% IMF.
Collapse
|
81
|
Ward T, Gordon J, Bennett H, Webster S, Sugrue D, Jones B, Brenner M, McEwan P. Tackling the burden of the hepatitis C virus in the UK: characterizing and assessing the clinical and economic consequences. Public Health 2016; 141:42-51. [PMID: 27932014 DOI: 10.1016/j.puhe.2016.08.002] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2016] [Revised: 08/03/2016] [Accepted: 08/05/2016] [Indexed: 01/18/2023]
Abstract
OBJECTIVES The hepatitis C virus (HCV) remains a significant public health issue. This study aimed to quantify the clinical and economic burden of chronic hepatitis C in the UK, stratified by disease severity, age and awareness of infection, with concurrent assessment of the impact of implementing a treatment prioritization approach. STUDY DESIGN AND METHODS A previously published back projection, natural history and cost-effectiveness HCV model was adapted to a UK setting to estimate the disease burden of chronic hepatitis C and end-stage liver disease (ESLD) between 1980 and 2035. A published meta-regression analysis informed disease progression, and UK-specific data informed other model inputs. RESULTS At 2015, prevalence of chronic hepatitis C is estimated to be 241,487 with 22.20%, 33.72%, 17.22%, 16.67% and 10.19% of patients in METAVIR stages F0, F1, F2, F3 and F4, respectively, but is estimated to fall to 193,999 by 2035. ESLD incidence is predicted to peak in 2031. Assuming all patients are diagnosed and treatment is prioritized in F3 and F4 using highly efficacious direct-acting antiviral (DAA) regimens, a 69.85% reduction in ESLD incidence is predicted between 2015 and 2035, and the cumulative discounted medical expenditure associated with the lifetime management of incident ESLD events is estimated to be £1,202,827,444. CONCLUSIONS The prevalence of chronic hepatitis C is expected to fall in coming decades; however, the ongoing financial burden is expected to be high due to an increase in ESLD incidence. This study highlights the significant costs of managing ESLD that are likely to be incurred without the employment of effective treatment approaches.
Collapse
|
82
|
Asaduzzaman M, Nadeem A, Arizmendi N, Davidson C, Nichols HL, Abel M, Ionescu LI, Puttagunta L, Thebaud B, Gordon J, DeFea K, Hollenberg MD, Vliagoftis H. Functional inhibition of PAR2 alleviates allergen-induced airway hyperresponsiveness and inflammation. Clin Exp Allergy 2016; 45:1844-55. [PMID: 26312432 DOI: 10.1111/cea.12628] [Citation(s) in RCA: 43] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2014] [Revised: 05/28/2015] [Accepted: 06/07/2015] [Indexed: 12/22/2022]
Abstract
BACKGROUND Proteinase-activated receptor 2 (PAR2 ) is a G protein-coupled receptor activated by trypsin-like serine proteinases. PAR2 activation has been associated with inflammation including allergic airway inflammation. We have also shown that PAR2 activation in the airways leads to allergic sensitization. The exact contribution of PAR2 in the development of eosinophilic inflammation and airway hyperresponsiveness (AHR) in sensitized individuals is not clear. OBJECTIVE To investigate whether functional inhibition of PAR2 during allergen challenge of allergic mice would inhibit allergen-induced AHR and inflammation in mouse models of asthma. METHODS Mice were sensitized and challenged with ovalbumin (OVA) or cockroach extract (CE). To investigate the role of PAR2 in the development of AHR and airway inflammation, we administered blocking anti-PAR2 antibodies, or a cell permeable peptide inhibitor of PAR2 signalling, pepducin, i.n. before allergen challenges and then assessed AHR and airway inflammation. RESULTS Administration of anti-PAR2 antibodies significantly inhibited OVA- and CE-induced AHR and airway inflammation. In particular, two anti-PAR2 antibodies, the monoclonal SAM-11 and polyclonal B5, inhibited AHR, airway eosinophilia, the increase of cytokines in the lung tissue and antigen-specific T cell proliferation, but had no effect on antigen-specific IgG and IgE levels. Pepducin was also effective in inhibiting AHR and airway inflammation in an OVA model of allergic airway inflammation. CONCLUSIONS AND CLINICAL RELEVANCE Functional blockade of PAR2 in the airways during allergen challenge improves allergen-induced AHR and inflammation in mice. Therefore, topical PAR2 blockade in the airways, through anti-PAR2 antibodies or molecules that interrupt PAR2 signalling, has the potential to be used as a therapeutic option in allergic asthma.
Collapse
|
83
|
Gorham PW, Nam J, Romero-Wolf A, Hoover S, Allison P, Banerjee O, Beatty JJ, Belov K, Besson DZ, Binns WR, Bugaev V, Cao P, Chen C, Chen P, Clem JM, Connolly A, Dailey B, Deaconu C, Cremonesi L, Dowkontt PF, DuVernois MA, Field RC, Fox BD, Goldstein D, Gordon J, Hast C, Hebert CL, Hill B, Hughes K, Hupe R, Israel MH, Javaid A, Kowalski J, Lam J, Learned JG, Liewer KM, Liu TC, Link JT, Lusczek E, Matsuno S, Mercurio BC, Miki C, Miočinović P, Mottram M, Mulrey K, Naudet CJ, Ng J, Nichol RJ, Palladino K, Rauch BF, Reil K, Roberts J, Rosen M, Rotter B, Russell J, Ruckman L, Saltzberg D, Seckel D, Schoorlemmer H, Stafford S, Stockham J, Stockham M, Strutt B, Tatem K, Varner GS, Vieregg AG, Walz D, Wissel SA, Wu F. Characteristics of Four Upward-Pointing Cosmic-Ray-like Events Observed with ANITA. PHYSICAL REVIEW LETTERS 2016; 117:071101. [PMID: 27563945 DOI: 10.1103/physrevlett.117.071101] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/11/2016] [Indexed: 06/06/2023]
Abstract
We report on four radio-detected cosmic-ray (CR) or CR-like events observed with the Antarctic Impulsive Transient Antenna (ANITA), a NASA-sponsored long-duration balloon payload. Two of the four were previously identified as stratospheric CR air showers during the ANITA-I flight. A third stratospheric CR was detected during the ANITA-II flight. Here, we report on characteristics of these three unusual CR events, which develop nearly horizontally, 20-30 km above the surface of Earth. In addition, we report on a fourth steeply upward-pointing ANITA-I CR-like radio event which has characteristics consistent with a primary that emerged from the surface of the ice. This suggests a possible τ-lepton decay as the origin of this event, but such an interpretation would require significant suppression of the standard model τ-neutrino cross section.
Collapse
|
84
|
Kaminski R, Bella R, Yin C, Otte J, Ferrante P, Gendelman HE, Li H, Booze R, Gordon J, Hu W, Khalili K. Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study. Gene Ther 2016; 23:696. [PMID: 27488023 DOI: 10.1038/gt.2016.45] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
85
|
Carter D, Gordon J, Watt AM. Competing Principles for Allocating Health Care Resources. THE JOURNAL OF MEDICINE AND PHILOSOPHY 2016; 41:558-83. [DOI: 10.1093/jmp/jhw017] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
86
|
Aab A, Abreu P, Aglietta M, Ahn EJ, Al Samarai I, Albuquerque IFM, Allekotte I, Allison P, Almela A, Alvarez Castillo J, Alvarez-Muñiz J, Alves Batista R, Ambrosio M, Aminaei A, Anastasi GA, Anchordoqui L, Andringa S, Aramo C, Arqueros F, Arsene N, Asorey H, Assis P, Aublin J, Avila G, Awal N, Badescu AM, Baus C, Beatty JJ, Becker KH, Bellido JA, Berat C, Bertaina ME, Bertou X, Biermann PL, Billoir P, Blaess SG, Blanco A, Blanco M, Blazek J, Bleve C, Blümer H, Boháčová M, Boncioli D, Bonifazi C, Borodai N, Brack J, Brancus I, Bretz T, Bridgeman A, Brogueira P, Buchholz P, Bueno A, Buitink S, Buscemi M, Caballero-Mora KS, Caccianiga B, Caccianiga L, Candusso M, Caramete L, Caruso R, Castellina A, Cataldi G, Cazon L, Cester R, Chavez AG, Chiavassa A, Chinellato JA, Chudoba J, Cilmo M, Clay RW, Cocciolo G, Colalillo R, Coleman A, Collica L, Coluccia MR, Conceição R, Contreras F, Cooper MJ, Cordier A, Coutu S, Covault CE, Cronin J, Dallier R, Daniel B, Dasso S, Daumiller K, Dawson BR, de Almeida RM, de Jong SJ, De Mauro G, de Mello Neto JRT, De Mitri I, de Oliveira J, de Souza V, Del Peral L, Deligny O, Dhital N, Di Giulio C, Di Matteo A, Diaz JC, Díaz Castro ML, Diogo F, Dobrigkeit C, Docters W, D'Olivo JC, Dorofeev A, Dorosti Hasankiadeh Q, Dos Anjos RC, Dova MT, Ebr J, Engel R, Erdmann M, Erfani M, Escobar CO, Espadanal J, Etchegoyen A, Falcke H, Fang K, Farrar G, Fauth AC, Fazzini N, Ferguson AP, Fick B, Figueira JM, Filevich A, Filipčič A, Fratu O, Freire MM, Fujii T, García B, Garcia-Gamez D, Garcia-Pinto D, Gate F, Gemmeke H, Gherghel-Lascu A, Ghia PL, Giaccari U, Giammarchi M, Giller M, Głas D, Glaser C, Glass H, Golup G, Gómez Berisso M, Gómez Vitale PF, González N, Gookin B, Gordon J, Gorgi A, Gorham P, Gouffon P, Griffith N, Grillo AF, Grubb TD, Guarino F, Guedes GP, Hampel MR, Hansen P, Harari D, Harrison TA, Hartmann S, Harton JL, Haungs A, Hebbeker T, Heck D, Heimann P, Herve AE, Hill GC, Hojvat C, Hollon N, Holt E, Homola P, Hörandel JR, Horvath P, Hrabovský M, Huber D, Huege T, Insolia A, Isar PG, Jandt I, Jansen S, Jarne C, Johnsen JA, Josebachuili M, Kääpä A, Kambeitz O, Kampert KH, Kasper P, Katkov I, Keilhauer B, Kemp E, Kieckhafer RM, Klages HO, Kleifges M, Kleinfeller J, Krause R, Krohm N, Kuempel D, Kukec Mezek G, Kunka N, Kuotb Awad AW, LaHurd D, Latronico L, Lauer R, Lauscher M, Lautridou P, Le Coz S, Lebrun D, Lebrun P, Leigui de Oliveira MA, Letessier-Selvon A, Lhenry-Yvon I, Link K, Lopes L, López R, López Casado A, Louedec K, Lucero A, Malacari M, Mallamaci M, Maller J, Mandat D, Mantsch P, Mariazzi AG, Marin V, Mariş IC, Marsella G, Martello D, Martinez H, Martínez Bravo O, Martraire D, Masías Meza JJ, Mathes HJ, Mathys S, Matthews J, Matthews JAJ, Matthiae G, Maurizio D, Mayotte E, Mazur PO, Medina C, Medina-Tanco G, Meissner R, Mello VBB, Melo D, Menshikov A, Messina S, Micheletti MI, Middendorf L, Minaya IA, Miramonti L, Mitrica B, Molina-Bueno L, Mollerach S, Montanet F, Morello C, Mostafá M, Moura CA, Muller MA, Müller G, Müller S, Navas S, Necesal P, Nellen L, Nelles A, Neuser J, Nguyen PH, Niculescu-Oglinzanu M, Niechciol M, Niemietz L, Niggemann T, Nitz D, Nosek D, Novotny V, Nožka L, Núñez LA, Ochilo L, Oikonomou F, Olinto A, Pacheco N, Pakk Selmi-Dei D, Palatka M, Pallotta J, Papenbreer P, Parente G, Parra A, Paul T, Pech M, Pȩkala J, Pelayo R, Pepe IM, Perrone L, Petermann E, Peters C, Petrera S, Petrov Y, Phuntsok J, Piegaia R, Pierog T, Pieroni P, Pimenta M, Pirronello V, Platino M, Plum M, Porcelli A, Porowski C, Prado RR, Privitera P, Prouza M, Quel EJ, Querchfeld S, Quinn S, Rautenberg J, Ravel O, Ravignani D, Reinert D, Revenu B, Ridky J, Risse M, Ristori P, Rizi V, Rodrigues de Carvalho W, Rodriguez Rojo J, Rodríguez-Frías MD, Rogozin D, Rosado J, Roth M, Roulet E, Rovero AC, Saffi SJ, Saftoiu A, Salazar H, Saleh A, Salesa Greus F, Salina G, Sanabria Gomez JD, Sánchez F, Sanchez-Lucas P, Santos E, Santos EM, Sarazin F, Sarkar B, Sarmento R, Sarmiento-Cano C, Sato R, Scarso C, Schauer M, Scherini V, Schieler H, Schmidt D, Scholten O, Schoorlemmer H, Schovánek P, Schröder FG, Schulz A, Schulz J, Schumacher J, Sciutto SJ, Segreto A, Settimo M, Shadkam A, Shellard RC, Sigl G, Sima O, Śmiałkowski A, Šmída R, Snow GR, Sommers P, Sonntag S, Sorokin J, Squartini R, Srivastava YN, Stanca D, Stanič S, Stapleton J, Stasielak J, Stephan M, Stutz A, Suarez F, Suarez Durán M, Suomijärvi T, Supanitsky AD, Sutherland MS, Swain J, Szadkowski Z, Taborda OA, Tapia A, Tepe A, Theodoro VM, Timmermans C, Todero Peixoto CJ, Toma G, Tomankova L, Tomé B, Tonachini A, Torralba Elipe G, Torres Machado D, Travnicek P, Trini M, Ulrich R, Unger M, Urban M, Valdés Galicia JF, Valiño I, Valore L, van Aar G, van Bodegom P, van den Berg AM, van Velzen S, van Vliet A, Varela E, Vargas Cárdenas B, Varner G, Vasquez R, Vázquez JR, Vázquez RA, Veberič D, Verzi V, Vicha J, Videla M, Villaseñor L, Vlcek B, Vorobiov S, Wahlberg H, Wainberg O, Walz D, Watson AA, Weber M, Weidenhaupt K, Weindl A, Welling C, Werner F, Widom A, Wiencke L, Wilczyński H, Winchen T, Wittkowski D, Wundheiler B, Wykes S, Yang L, Yapici T, Yushkov A, Zas E, Zavrtanik D, Zavrtanik M, Zepeda A, Zimmermann B, Ziolkowski M, Zuccarello F. Measurement of the Radiation Energy in the Radio Signal of Extensive Air Showers as a Universal Estimator of Cosmic-Ray Energy. PHYSICAL REVIEW LETTERS 2016; 116:241101. [PMID: 27367377 DOI: 10.1103/physrevlett.116.241101] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/27/2015] [Indexed: 06/06/2023]
Abstract
We measure the energy emitted by extensive air showers in the form of radio emission in the frequency range from 30 to 80 MHz. Exploiting the accurate energy scale of the Pierre Auger Observatory, we obtain a radiation energy of 15.8±0.7(stat)±6.7(syst) MeV for cosmic rays with an energy of 1 EeV arriving perpendicularly to a geomagnetic field of 0.24 G, scaling quadratically with the cosmic-ray energy. A comparison with predictions from state-of-the-art first-principles calculations shows agreement with our measurement. The radiation energy provides direct access to the calorimetric energy in the electromagnetic cascade of extensive air showers. Comparison with our result thus allows the direct calibration of any cosmic-ray radio detector against the well-established energy scale of the Pierre Auger Observatory.
Collapse
|
87
|
Chetvertkov M, Siddiqui F, Chetty I, Kumarasiri A, Liu C, Gordon J. SU-F-R-41: Regularized PCA Can Model Treatment-Related Changes in Head and Neck Patients Using Daily CBCTs. Med Phys 2016. [DOI: 10.1118/1.4955812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
88
|
Gaul E, Toncian T, Martinez M, Gordon J, Spinks M, Dyer G, Truong N, Wagner C, Tiwari G, Donovan ME, Ditmire T, Hegelich BM. Improved pulse contrast on the Texas Petawatt Laser. ACTA ACUST UNITED AC 2016. [DOI: 10.1088/1742-6596/717/1/012092] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
89
|
Mungrue K, Chase H, Gordon J, Knowles D, Lockhart K, Miller N, Morley T, Sealey L, Turner B. Breast Cancer in the Bahamas in 2009-2011. BREAST CANCER-BASIC AND CLINICAL RESEARCH 2016; 10:45-52. [PMID: 27127408 PMCID: PMC4841291 DOI: 10.4137/bcbcr.s32792] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/26/2015] [Revised: 10/15/2015] [Accepted: 10/19/2015] [Indexed: 01/13/2023]
Abstract
BACKGROUND Breast cancer is the most common form of cancer affecting women in the Bahamas, which consists of many islands. This is the first attempt to identify which island has the highest occurrence of breast cancer. OBJECTIVE The aim of this study was to describe the sociodemographical and spatial features of breast cancer in the Bahamas in 2009-2011. METHODS A review of the medical records of all women with a confirmed diagnosis of breast cancer during the period January 1, 2009-December 31, 2011, was undertaken. Data were first obtained from the National Oncology Board of the Bahamas and validated by a review of the medical records. The patient address was geocoded and mapped using ArcGIS 10.0 Environmental Systems Research Institute (ESRI) to satellite images obtained from The Nature Conservancy in the Bahamas. RESULTS We recruited 270 patients who satisfied the entry criteria. The cumulative incidences of breast cancer for the years 2009-2011 were 51.4, 45.4, and 51.4, respectively. Breast cancer occurred most often in women of African origin with a mean age at diagnosis of 56.6 ± 13.8 years. Ductal carcinoma was the most common histological type observed with most cancers occurring in Grade II or higher and presenting as late stage (≥ Stage II). Surgery was the preferred method of treatment with modified radical mastectomy being the procedure of choice. Spatial distribution of cases across the Bahamas revealed one cluster, which is present on the island of New Providence. Further analysis of New Providence showed a consistently skewed kernel density in the central and eastern regions, compared with a scattered distribution in the southern and western regions. CONCLUSION The island of New Providence had the highest occurrence of breast cancer among all the islands of the Bahamas. The increasing incidence of breast cancer in young women is likely to impose a significant burden on the future of Bahamian health care.
Collapse
|
90
|
Kennedy NA, Warner B, Johnston EL, Flanders L, Hendy P, Ding NS, Harris R, Fadra AS, Basquill C, Lamb CA, Cameron FL, Murray CD, Parkes M, Gooding I, Ahmad T, Gaya DR, Mann S, Lindsay JO, Gordon J, Satsangi J, Hart A, McCartney S, Irving P, Lees CW. Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis. Aliment Pharmacol Ther 2016; 43:910-923. [PMID: 26892328 PMCID: PMC4793922 DOI: 10.1111/apt.13547] [Citation(s) in RCA: 84] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/23/2015] [Revised: 08/11/2015] [Accepted: 01/14/2016] [Indexed: 12/12/2022]
Abstract
BACKGROUND Infliximab and adalimumab have established roles in inflammatory bowel disease (IBD) therapy. UK regulators mandate reassessment after 12 months' anti-TNF therapy for IBD, with consideration of treatment withdrawal. There is a need for more data to establish the relapse rates following treatment cessation. AIM To establish outcomes following anti-TNF withdrawal for sustained remission using new data from a large UK cohort, and assimilation of all available literature for systematic review and meta-analysis. METHODS A retrospective observational study was performed on 166 patients with IBD (146 with Crohn's disease (CD) and 20 with ulcerative colitis [UC) and IBD unclassified (IBDU)] withdrawn from anti-TNF for sustained remission. Meta-analysis was undertaken of all published studies incorporating 11 further cohorts totalling 746 patients (624 CD, 122 UC). RESULTS Relapse rates in the UK cohort were 36% by 1 year and 56% by 2 years for CD, and 42% by 1 year and 47% by 2 years for UC/IBDU. Increased relapse risk in CD was associated with age at diagnosis [hazard ratio (HR) 2.78 for age <22 years], white cell count (HR 3.22 for >5.25 × 109 /L) and faecal calprotectin (HR 2.95 for >50 μg/g) at drug withdrawal. Neither continued immunomodulators nor endoscopic remission were predictors. In the meta-analysis, estimated 1-year relapse rates were 39% and 35% for CD and UC/IBDU respectively. Retreatment with anti-TNF was successful in 88% for CD and 76% UC/IBDU. CONCLUSIONS Assimilation of all available data reveals remarkable homogeneity. Approximately one-third of patients with IBD flare within 12 months of withdrawal of anti-TNF therapy for sustained remission.
Collapse
|
91
|
Kaambwa B, Ratcliffe J, Bradley SL, Masters S, Davies O, Whitehead C, Milte C, Cameron ID, Young T, Gordon J, Crotty M. Costs and advance directives at the end of life: a case of the 'Coaching Older Adults and Carers to have their preferences Heard (COACH)' trial. BMC Health Serv Res 2015; 15:545. [PMID: 26645745 PMCID: PMC4673742 DOI: 10.1186/s12913-015-1201-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2015] [Accepted: 11/30/2015] [Indexed: 12/31/2022] Open
Abstract
Background Total costs associated with care for older people nearing the end of life and the cost variations related with end of life care decisions are not well documented in the literature. Healthcare utilisation and associated health care costs for a group of older Australians who entered Transition Care following an acute hospital admission were calculated. Costs were differentiated according to a number of health care decisions and outcomes including advance directives (ADs). Methods Study participants were drawn from the Coaching Older Adults and Carers to have their preferences Heard (COACH) trial funded by the Australian National Health and Medical Research Council. Data collected included total health care costs, the type of (and when) ADs were completed and the place of death. Two-step endogenous treatment-regression models were employed to test the relationship between costs and a number of variables including completion of ADs. Results The trial recruited 230 older adults with mean age 84 years. At the end of the trial, 53 had died and 80 had completed ADs. Total healthcare costs were higher for younger participants and those who had died. No statistically significant association was found between costs and completion of ADs. Conclusion For our frail study population, the completion of ADs did not have an effect on health care utilisation and costs. Further research is needed to substantiate these findings in larger and more diverse clinical cohorts of older people. Trial registration This study was registered on 13/12/2007 with the Australian New Zealand Clinical Trial Registry (ACTRN12607000638437).
Collapse
|
92
|
Popat S, Felip E, Cobo M, Fulop A, Dayen C, Trigo J, Gregg R, Waller C, Gordon J, Lorence R, Wang B, Chand V, Hirsh V. 3085 Second-line afatinib vs erlotinib in patients with advanced squamous cell carcinoma (SCC) of the lung: patient-reported outcome (PRO) data from the global LUX-Lung 8 (LL8) Phase III trial. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31726-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
93
|
Li E, Hanson B, Gordon J, DiMattina M, Celia G, Payson M. Evaluating oocyte yield, quality & fertilization following a change in anesthesia protocol. Fertil Steril 2015. [DOI: 10.1016/j.fertnstert.2015.07.569] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
94
|
Liu C, Kumarasiri A, Chetvertkov M, Gordon J, Chetty I, Siddiqui F, Kim J. SU-E-J-114: A Practical Hybrid Method for Improving the Quality of CT-CBCT Deformable Image Registration for Head and Neck Radiotherapy. Med Phys 2015. [DOI: 10.1118/1.4924201] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
95
|
Snyder K, Kim J, Reding A, Fraser C, Lu S, Gordon J, Ajlouni M, Movsas B, Chetty I. MO-F-CAMPUS-T-04: Development and Evaluation of a Knowledge-Based Model for Treatment Planning of Lung Cancer Patients Using Stereotactic Body Radiotherapy (SBRT). Med Phys 2015. [DOI: 10.1118/1.4925460] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
96
|
Aab A, Abreu P, Aglietta M, Ahn EJ, Samarai IA, Albuquerque IFM, Allekotte I, Allen J, Allison P, Almela A, Castillo JA, Alvarez-Muñiz J, Batista RA, Ambrosio M, Aminaei A, Anchordoqui L, Andringa S, Aramo C, Aranda VM, Arqueros F, Asorey H, Assis P, Aublin J, Ave M, Avenier M, Avila G, Awal N, Badescu AM, Barber KB, Bäuml J, Baus C, Beatty JJ, Becker KH, Bellido JA, Berat C, Bertaina ME, Bertou X, Biermann PL, Billoir P, Blaess S, Blanco M, Bleve C, Blümer H, Boháčová M, Boncioli D, Bonifazi C, Bonino R, Borodai N, Brack J, Brancus I, Bridgeman A, Brogueira P, Brown WC, Buchholz P, Bueno A, Buitink S, Buscemi M, Caballero-Mora KS, Caccianiga B, Caccianiga L, Candusso M, Caramete L, Caruso R, Castellina A, Cataldi G, Cazon L, Cester R, Chavez AG, Chiavassa A, Chinellato JA, Chudoba J, Cilmo M, Clay RW, Cocciolo G, Colalillo R, Coleman A, Collica L, Coluccia MR, Conceição R, Contreras F, Cooper MJ, Cordier A, Coutu S, Covault CE, Cronin J, Curutiu A, Dallier R, Daniel B, Dasso S, Daumiller K, Dawson BR, Almeida RMD, Domenico MD, Jong SJD, Neto JRTDM, Mitri ID, Oliveira JD, Souza VD, Peral LD, Deligny O, Dembinski H, Dhital N, Giulio CD, Matteo AD, Diaz JC, Castro MLD, Diogo F, Dobrigkeit C, Docters W, D’Olivo JC, Dorofeev A, Hasankiadeh QD, Dova MT, Ebr J, Engel R, Erdmann M, Erfani M, Escobar CO, Espadanal J, Etchegoyen A, Luis PFS, Falcke H, Fang K, Farrar G, Fauth AC, Fazzini N, Ferguson AP, Fernandes M, Fick B, Figueira JM, Filevich A, Filipčič A, Fox BD, Fratu O, Fröhlich U, Fuchs B, Fujii T, Gaior R, García B, Roca STG, Garcia-Gamez D, Garcia-Pinto D, Garilli G, Bravo AG, Gate F, Gemmeke H, Ghia PL, Giaccari U, Giammarchi M, Giller M, Glaser C, Glass H, Berisso MG, Vitale PFG, Gonçalves P, Gonzalez JG, González N, Gookin B, Gordon J, Gorgi A, Gorham P, Gouffon P, Grebe S, Griffith N, Grillo AF, Grubb TD, Guarino F, Guedes GP, Hampel MR, Hansen P, Harari D, Harrison TA, Hartmann S, Harton JL, Haungs A, Hebbeker T, Heck D, Heimann P, Herve AE, Hill GC, Hojvat C, Hollon N, Holt E, Homola P, Hörandel JR, Horvath P, Hrabovský M, Huber D, Huege T, Insolia A, Isar PG, Jandt I, Jansen S, Jarne C, Josebachuili M, Kääpä A, Kambeitz O, Kampert KH, Kasper P, Katkov I, Kégl B, Keilhauer B, Keivani A, Kemp E, Kieckhafer RM, Klages HO, Kleifges M, Kleinfeller J, Krause R, Krohm N, Krömer O, Kruppke-Hansen D, Kuempel D, Kunka N, LaHurd D, Latronico L, Lauer R, Lauscher M, Lautridou P, Coz SL, Leão MSAB, Lebrun D, Lebrun P, Oliveira MALD, Letessier-Selvon A, Lhenry-Yvon I, Link K, López R, Agüera AL, Louedec K, Bahilo JL, Lu L, Lucero A, Ludwig M, Malacari M, Maldera S, Mallamaci M, Maller J, Mandat D, Mantsch P, Mariazzi AG, Marin V, Mariş IC, Marsella G, Martello D, Martin L, Martinez H, Bravo OM, Martraire D, Meza JJM, Mathes HJ, Mathys S, Matthews J, Matthews JAJ, Matthiae G, Maurel D, Maurizio D, Mayotte E, Mazur PO, Medina C, Medina-Tanco G, Meissner R, Melissas M, Melo D, Menshikov A, Messina S, Meyhandan R, Mićanović S, Micheletti MI, Middendorf L, Minaya IA, Miramonti L, Mitrica B, Molina-Bueno L, Mollerach S, Monasor M, Ragaigne DM, Montanet F, Morello C, Mostafá M, Moura CA, Muller MA, Müller G, Müller S, Münchmeyer M, Mussa R, Navarra G, Navas S, Necesal P, Nellen L, Nelles A, Neuser J, Nguyen P, Niechciol M, Niemietz L, Niggemann T, Nitz D, Nosek D, Novotny V, Nožka L, Ochilo L, Olinto A, Oliveira M, Pacheco N, Selmi-Dei DP, Palatka M, Pallotta J, Palmieri N, Papenbreer P, Parente G, Parra A, Paul T, Pech M, Pȩkala J, Pelayo R, Pepe IM, Perrone L, Petermann E, Peters C, Petrera S, Petrov Y, Phuntsok J, Piegaia R, Pierog T, Pieroni P, Pimenta M, Pirronello V, Platino M, Plum M, Porcelli A, Porowski C, Prado RR, Privitera P, Prouza M, Purrello V, Quel EJ, Querchfeld S, Quinn S, Rautenberg J, Ravel O, Ravignani D, Revenu B, Ridky J, Riggi S, Risse M, Ristori P, Rizi V, Carvalho WRD, Cabo IR, Fernandez GR, Rojo JR, Rodríguez-Frías MD, Rogozin D, Ros G, Rosado J, Rossler T, Roth M, Roulet E, Rovero AC, Saffi SJ, Saftoiu A, Salamida F, Salazar H, Saleh A, Greus FS, Salina G, Sánchez F, Sanchez-Lucas P, Santo CE, Santos E, Santos EM, Sarazin F, Sarkar B, Sarmento R, Sato R, Scharf N, Scherini V, Schieler H, Schiffer P, Schmidt D, Schröder FG, Scholten O, Schoorlemmer H, Schovánek P, Schulz A, Schulz J, Schumacher J, Sciutto SJ, Segreto A, Settimo M, Shadkam A, Shellard RC, Sidelnik I, Sigl G, Sima O, kowski AŚ, Šmída R, Snow GR, Sommers P, Sorokin J, Squartini R, Srivastava YN, Stanič S, Stapleton J, Stasielak J, Stephan M, Stutz A, Suarez F, Suomijärvi T, Supanitsky AD, Sutherland MS, Swain J, Szadkowski Z, Szuba M, Taborda OA, Tapia A, Tartare M, Tepe A, Theodoro VM, Timmermans C, Peixoto CJT, Toma G, Tomankova L, Tomé B, Tonachini A, Elipe GT, Machado DT, Travnicek P, Trovato E, Tueros M, Ulrich R, Unger M, Urban M, Galicia JFV, Valiño I, Valore L, Aar GV, Bodegom PV, Berg AMVD, Velzen SV, Vliet AV, Varela E, Vargas Cárdenas B, Varner G, Vázquez JR, Vázquez RA, Veberič D, Verzi V, Vicha J, Videla M, Villaseñor L, Vlcek B, Vorobiov S, Wahlberg H, Wainberg O, Walz D, Watson AA, Weber M, Weidenhaupt K, Weindl A, Werner F, Widom A, Wiencke L, Wilczyńska B, Wilczyński H, Will M, Williams C, Winchen T, Wittkowski D, Wundheiler B, Wykes S, Yamamoto T, Yapici T, Yuan G, Yushkov A, Zamorano B, Zas E, Zavrtanik D, Zavrtanik M, Zaw I, Zepeda A, Zhou J, Zhu Y, Silva MZ, Ziolkowski M, Zuccarello F. Search for patterns by combining cosmic-ray energy and arrival directions at the Pierre Auger Observatory. THE EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS 2015; 75:269. [PMID: 26120280 PMCID: PMC4477714 DOI: 10.1140/epjc/s10052-015-3471-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/03/2014] [Accepted: 05/20/2015] [Indexed: 06/04/2023]
Abstract
Energy-dependent patterns in the arrival directions of cosmic rays are searched for using data of the Pierre Auger Observatory. We investigate local regions around the highest-energy cosmic rays with [Formula: see text] eV by analyzing cosmic rays with energies above [Formula: see text] eV arriving within an angular separation of approximately 15[Formula: see text]. We characterize the energy distributions inside these regions by two independent methods, one searching for angular dependence of energy-energy correlations and one searching for collimation of energy along the local system of principal axes of the energy distribution. No significant patterns are found with this analysis. The comparison of these measurements with astrophysical scenarios can therefore be used to obtain constraints on related model parameters such as strength of cosmic-ray deflection and density of point sources.
Collapse
|
97
|
Chetvertkov M, Siddiqui F, Chetty I, Kim J, Kumarasiri A, Liu C, Gordon J. SU-E-J-257: A PCA Model to Predict Adaptive Changes for Head&neck Patients Based On Extraction of Geometric Features From Daily CBCT Datasets. Med Phys 2015. [DOI: 10.1118/1.4924343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
98
|
Zhong H, Li H, Gordon J, Chetty I. TU-F-CAMPUS-J-03: Elasticity Functions Based On 4DCT Images to Predict Tumor and Normal Tissue Response to Radiation for Patients with Lung Cancers. Med Phys 2015. [DOI: 10.1118/1.4925808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
99
|
Song K, Wen N, Qin Y, Kim J, Li H, Snyder K, Gordon J, Chetty I, Siddiqui S. SU-E-T-402: Evaluation of the Accuracy of a Novel Open Mask System for Immobilization of Cranial Stereotactic Radiosurgery Patients. Med Phys 2015. [DOI: 10.1118/1.4924763] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
100
|
Li H, Zhong H, Song K, Qin Y, Snyder K, Gordon J, Chetty I, Wen N. SU-E-T-757: TMRs Calculated From PDDs Versus the Direct Measurements for Small Field SRS Cones. Med Phys 2015. [DOI: 10.1118/1.4925121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|